⌘K
| Date | TitleTitle | |||
|---|---|---|---|---|
| 06/12/21 | 07:00:09 | 6 Dec 2021 | Positive results from Flu Human Challenge Study | |
| 19/11/21 | 07:00:03 | 19 Nov 2021 | Imutex Vaccine Phase I Study Results | |
| 17/11/21 | 07:00:05 | 17 Nov 2021 | £5.1m RSV contract | |
| 15/11/21 | 07:00:05 | 15 Nov 2021 | £1.5m Contract renewal for Venn Life Sciences | |
| 13/10/21 | 07:00:09 | 13 Oct 2021 | Directorate Change | |
| 20/09/21 | 07:00:08 | 20 Sept 2021 | Half-year Report | |
| 20/09/21 | 07:00:07 | 20 Sept 2021 | £5.7m Influenza human challenge study contract win | |
| 09/09/21 | 07:00:07 | 9 Sept 2021 | Notice of Results | |
| 07/09/21 | 07:00:05 | 7 Sept 2021 | Positive results from RSV Human Challenge Study | |
| 24/08/21 | 09:05:33 | 24 Aug 2021 | Second Price Monitoring Extn | |
| 24/08/21 | 09:00:37 | 24 Aug 2021 | Price Monitoring Extension | |
| 24/08/21 | 07:00:03 | 24 Aug 2021 | £8.1m Asthma Human Challenge Study Contract Win |
| Date | TitleTitle | |||
|---|---|---|---|---|
| 06/12/21 | 07:00:09 | 6 Dec 2021 | Positive results from Flu Human Challenge Study | |
| 19/11/21 | 07:00:03 | 19 Nov 2021 | Imutex Vaccine Phase I Study Results | |
| 17/11/21 | 07:00:05 | 17 Nov 2021 | £5.1m RSV contract | |
| 15/11/21 | 07:00:05 | 15 Nov 2021 | £1.5m Contract renewal for Venn Life Sciences | |
| 13/10/21 | 07:00:09 | 13 Oct 2021 | Directorate Change | |
| 20/09/21 | 07:00:08 | 20 Sept 2021 | Half-year Report | |
| 20/09/21 | 07:00:07 | 20 Sept 2021 | £5.7m Influenza human challenge study contract win | |
| 09/09/21 | 07:00:07 | 9 Sept 2021 | Notice of Results | |
| 07/09/21 | 07:00:05 | 7 Sept 2021 | Positive results from RSV Human Challenge Study | |
| 24/08/21 | 09:05:33 | 24 Aug 2021 | Second Price Monitoring Extn | |
| 24/08/21 | 09:00:37 | 24 Aug 2021 | Price Monitoring Extension | |
| 24/08/21 | 07:00:03 | 24 Aug 2021 | £8.1m Asthma Human Challenge Study Contract Win |
